Effect of a scalp cooling device in the prevention of chemotherapy-induced alopecia in breast cancer patients

Kotani Haruru0 个研究点目标入组 16 人开始时间: 2019年3月6日最近更新: 2023年10月17日

适应症

试验速览

The results including successful hair preservation rate and adverse events were consistent with previous reports.

•1.ECOG performance status 0 or 1
•2.Adequate bone marrow,heart,liver and renal function
•3.Informed consent is obtainable from the subject herself in documented form using the Consent Form

•1.Previous chemotherapy treatment
•2.Already have alopecia >grade 1 by CTCAE v4.0
•3.History of migraine headaches, hypothyroidism, uncontrolled diabetes, and anorexia.
•4.Any condition for contraindication of chemotherapy
•5.Multiple active cancers (homochromous multiple cancers, or heterochromous multiple cancers with a cancer-free period of less than 5 years prior to randomization)
•Carcinoma in situ deemed to be cured by local treatment (lesions that are intraepithelial carcinoma or mucosal cancer) is not included as an active multiple cancer
•6.Difficulty to participate in this study due to mental illness or psychiatric symptoms
•7.Any other reasons recognized as inadequate to participate in this study by doctors

发起方

Kotani Haruru